Stay updated on CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.

Latest updates to the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page
- Check5 days agoChange DetectedRevision v3.5.0 was added to the revision history and revision v3.4.3 was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision history updated: added v3.4.3 entry and removed v3.4.2 entry from the Study Record Versions.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedAdded revision entry v3.4.2 to the Record History and removed revision v3.4.1.SummaryDifference0.1%

- Check48 days agoChange DetectedA new version entry v3.4.1 was added to the Record History and the previous v3.4.0 version was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check69 days agoChange DetectedThe history now shows the addition of revision v3.3.4 and the removal of revision v3.3.3 from the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedA new revision entry, Revision: v3.3.3, was added to the Record History. The HHS Vulnerability Disclosure item and Revision: v3.3.2 were removed.SummaryDifference0.2%

Stay in the know with updates to CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.